1. Additional file 1 of A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
- Author
-
Zhao, Tianming, He, Qiang, Xie, Shurong, Zhan, Huien, Jiang, Cheng, Lin, Shengbin, Liu, Fangshu, Wang, Cong, Chen, Guo, and Zeng, Hui
- Abstract
Additional file 1: Fig. S1. MI-238 selectively suppressed cell growth of H1299 parental cells but not Mcl-1 knockout (KO) cells. Fig. S2. H1299 Mcl-1 KO cells or mouse embryonic fibroblast (MEF) cells do not depend on Mcl-1 for survival. Fig. S3. Primary bone marrow cells with elevated expression level of Mcl-1 is more sensitive to MI-238. Fig. S4. The profiles of apoptosis analysis by annexin V/PI staining in Molm13 cells treated with indicated concentrations of MI-238 and venetoclax or their combinations. Fig. S5. The activation of Bak in Molm13 cells after 24 h of indicated treatment was analyzed by flow cytometry. Fig. S6. The representative annexin V/PI staining profiles of primary patient AML cells treated with indicated concentrations of MI-238 for 48 h. Fig. S7. 20 μM of MI-238 failed to induce apoptosis in mononuclear bone marrow cells from healthy donor.
- Published
- 2023
- Full Text
- View/download PDF